CPA
VKTX icon

Court Place Advisors’s Viking Therapeutics VKTX Stock Holding History

Court Place Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,800
Closed -$684K – 167
2024
Q3 		$684K Hold
10,800
– – 0.2% 88
2024
Q2 		$573K Buy
+10,800
New +$708K 0.18% 92
2024
Q1 		– Sell
-12,800
Closed -$238K – 167
2023
Q4 		$238K Hold
12,800
– – 0.08% 148
2023
Q3 		$142K Hold
12,800
– – 0.05% 157
2023
Q2 		$207K Hold
12,800
– – 0.07% 159
2023
Q1 		$213K Sell
12,800
-107,520
-89% -$1.11M 0.08% 154
2022
Q4 		$120K Buy
120,320
+107,520
+840% +$480K 0.04% 163
2022
Q3 		$35K Sell
12,800
-1,000
-7% -$3.27K 0.01% 156
2022
Q2 		$40K Hold
13,800
– – 0.02% 163
2022
Q1 		$41K Hold
13,800
– – 0.01% 174
2021
Q4 		$63K Hold
13,800
– – 0.02% 182
2021
Q3 		$87K Hold
13,800
– – 0.03% 176
2021
Q2 		$83K Hold
13,800
– – 0.02% 178
2021
Q1 		$87K Hold
13,800
– – 0.03% 178
2020
Q4 		$78K Hold
13,800
– – 0.03% 174
2020
Q3 		$80K Hold
13,800
– – 0.03% 166
2020
Q2 		$99K Hold
13,800
– – 0.04% 164
2020
Q1 		$65K Hold
13,800
– – 0.03% 156
2019
Q4 		$111K Hold
13,800
– – 0.04% 178
2019
Q3 		$95K Hold
13,800
– – 0.04% 173
2019
Q2 		$115K Hold
13,800
– – 0.05% 179
2019
Q1 		$137K Buy
13,800
+1,000
+8% +$8.37K 0.06% 175
2018
Q4 		$98K Buy
12,800
+2,000
+19% +$23.9K 0.04% 163
2018
Q3 		$188K Hold
10,800
– – 0.07% 173
2018
Q2 		$102K Buy
10,800
+800
+8% +$5.32K 0.04% 171
2018
Q1 		$44K Buy
+10,000
New +$55.3K 0.02% 168

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Court Place Advisors's VKTX Position: Q4 2024 in Review

Court Place Advisors sold out of Viking Therapeutics (VKTX) in Q4 2024, closing a stake of 10,800 shares — an estimated $684K sold.

Court Place Advisors first reported a position in VKTX in Q1 2018 and held it in 26 quarters. The position peaked at $684K in Q3 2024. 408 funds tracked by Wall St. Rank hold VKTX as of Q4 2024.

  • Court Place Advisors reported no remaining Viking Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Court Place Advisors sold 10,800 Viking Therapeutics shares in Q4 2024, an estimated $684K.
  • Court Place Advisors first reported a position in Viking Therapeutics in Q1 2018 and held it in 26 quarters.
  • Court Place Advisors's Viking Therapeutics position peaked at $684K in Q3 2024.
  • 408 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2024.

Based on Court Place Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.